MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
3. Triple Helix _ Dynamics
*Driving Forces: Triple Helix _ Translation, Commercialization, Technology Transfer, SBIR/STTR, OTA, NonTraditional / New Business Models
Triple Helix: Regional Innovation Clusters (RIC)s
Intermediaries: Triple Helix Regional Innovation Clusters (RIC)s
RICS (Regional Innovation Clusters) - Medical, Life Sciences & Emerging Technology Hotspots
*Industry: Ireland
Boston Scientific Corporation (NYSE:BSX)
Organization & Developments: Boston Scientific
*Developments: Boston Scientific
Parents
Organization & Developments: Boston Scientific
Children
*Boston Scientific is a medical device company with an expansive gastroenterology and cardiology portfolio.
*Developments: Boston Scientific (2004-2015)
2016: Boston Sci Accused of Racketeering, Using Counterfeit Resin
2016: Boston Scientific slicing up to $150 million in restructuring_modernhealthcare
2016: Boston Scientific, Google look to jumpstart digital health startups
2017: VA_65--Boston Scientific Coils Implants
2018: 6 startups enter Boston Scientific-funded medtech accelerator_Gener8tor announces newest startups in its gBETA med-tech accelerator - Minneapolis
2018: Boston Scientific planning up to $150M in annual cuts, 'limited' layoffs
2018: U.S. Army_MEDCOM_Boston Scientific Surgical Implants
2018: U.S. Army_MEDCOM_Spinal Cord Stimulator
2018: VA_65--NX Boston Scientific Radiofrequency (RF) Tissue Ablation System BNOE
2019: This Highly Rated Medtech Is Staring Down A Buy Point After Earnings Beat_www.investors.com
2019: U.S. Army_MEDCOM_Notice of Intent for Sole Source Award for Various Cardiac Implants
2021: Boston Scientific gets FDA nod for single-use bronchoscope, sees $2B opportunity
2022: Boston Scientific (BSX) Presents At Annual Scientific Meeting 2022 of HFSA - Slideshow_seekingalpha.com
2022: Boston Scientific’s Eluvia drug-eluting vascular stent system is a drug delivery device for the treatment of peripheral artery disease.
2023: Boston Scientific looks to new devices in 2024 to drive growth
2023: Boston Scientific still surging upward, with 12% sales bump amid product launches, M&A moves_fiercebiotech
2023: Delivering Strong Growth, But Sector Derating Is A Big Issue (NYSE:BSX)
2023: TCT: GE HealthCare links with Boston Scientific in cardiac imaging
2024: Boston Scientific Has Become A Standout Growth Story In Med-Tech
2024: Boston Scientific Profit and Sales Are Boosted by Cardiovascular Device Demand
2024: Boston Scientific: Continued M&A Drives More Growth_seekingalpha.com
2024: Boston Scientific: Implications Of The Axonics-Medtronic Patent Clash
2024: Boston Scientific: The Market's Newest Mega-Cap Needs A Breather
2024: Pulsed field ablation to ‘cannibalize’ radiofrequency, cryo:Needham
Jumps
*Organization: Boston Scientific